Cargando…

Marker events associated with adherence to HIV/AIDS treatment in a cohort study

OBJECTIVE: To analyze how clinical and social events may impact adherence to antiretroviral treatment for HIV. METHODS: This is a historical cohort study with 528 patients who underwent treatment for HIV in a specialized care service in Alvorada, RS. A total of 3429 queries executed between the year...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins, Rafael Steffens, Knauth, Daniela Riva, Vigo, Alvaro, Fisch, Patrícia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Saúde Pública da Universidade de São Paulo 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118423/
https://www.ncbi.nlm.nih.gov/pubmed/37075403
http://dx.doi.org/10.11606/s1518-8787.2023057004219
_version_ 1785028805659721728
author Martins, Rafael Steffens
Knauth, Daniela Riva
Vigo, Alvaro
Fisch, Patrícia
author_facet Martins, Rafael Steffens
Knauth, Daniela Riva
Vigo, Alvaro
Fisch, Patrícia
author_sort Martins, Rafael Steffens
collection PubMed
description OBJECTIVE: To analyze how clinical and social events may impact adherence to antiretroviral treatment for HIV. METHODS: This is a historical cohort study with 528 patients who underwent treatment for HIV in a specialized care service in Alvorada, RS. A total of 3429 queries executed between the years 2004 and 2017 were analyzed. For each visit, data on treatment characteristics and the patients’ clinical picture were collected. Adherence, as measured by patients’ self-report, was the endpoint of the study. The logistic regression model via generalized estimating equations was used for estimating the associations. RESULTS: 67.8% of the patients analyzed have up to 8 years of education and 24.8% have a history of crack and/or cocaine use. Among men, being asymptomatic [odds ratio (OR) = 1.43; 95%CI 1.05-1.93], having more than 8 years of education (OR= 2.32; 95%CI 1.27-4.23), and never having used crack (RC = 2.35; 95%CI 1.20-4.57) were associated with adherence. For women, being older than 24 years (CR = 1.82; 95%CI 1.09-3.02), never having used cocaine (CR = 2.54; 95%CI 1.32-4.88) and being pregnant (RC = 3.28; 95%CI 1.83-5.89) increased the odds of adherence. CONCLUSIONS: In addition to defined sociodemographic characteristics, one-off events that may occur in the trajectory of patients on long treatment, such as starting a new pregnancy and not having symptoms, can impact patients’ chances of treatment adherence.
format Online
Article
Text
id pubmed-10118423
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Faculdade de Saúde Pública da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-101184232023-04-21 Marker events associated with adherence to HIV/AIDS treatment in a cohort study Martins, Rafael Steffens Knauth, Daniela Riva Vigo, Alvaro Fisch, Patrícia Rev Saude Publica Original Article OBJECTIVE: To analyze how clinical and social events may impact adherence to antiretroviral treatment for HIV. METHODS: This is a historical cohort study with 528 patients who underwent treatment for HIV in a specialized care service in Alvorada, RS. A total of 3429 queries executed between the years 2004 and 2017 were analyzed. For each visit, data on treatment characteristics and the patients’ clinical picture were collected. Adherence, as measured by patients’ self-report, was the endpoint of the study. The logistic regression model via generalized estimating equations was used for estimating the associations. RESULTS: 67.8% of the patients analyzed have up to 8 years of education and 24.8% have a history of crack and/or cocaine use. Among men, being asymptomatic [odds ratio (OR) = 1.43; 95%CI 1.05-1.93], having more than 8 years of education (OR= 2.32; 95%CI 1.27-4.23), and never having used crack (RC = 2.35; 95%CI 1.20-4.57) were associated with adherence. For women, being older than 24 years (CR = 1.82; 95%CI 1.09-3.02), never having used cocaine (CR = 2.54; 95%CI 1.32-4.88) and being pregnant (RC = 3.28; 95%CI 1.83-5.89) increased the odds of adherence. CONCLUSIONS: In addition to defined sociodemographic characteristics, one-off events that may occur in the trajectory of patients on long treatment, such as starting a new pregnancy and not having symptoms, can impact patients’ chances of treatment adherence. Faculdade de Saúde Pública da Universidade de São Paulo 2023-03-29 /pmc/articles/PMC10118423/ /pubmed/37075403 http://dx.doi.org/10.11606/s1518-8787.2023057004219 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Martins, Rafael Steffens
Knauth, Daniela Riva
Vigo, Alvaro
Fisch, Patrícia
Marker events associated with adherence to HIV/AIDS treatment in a cohort study
title Marker events associated with adherence to HIV/AIDS treatment in a cohort study
title_full Marker events associated with adherence to HIV/AIDS treatment in a cohort study
title_fullStr Marker events associated with adherence to HIV/AIDS treatment in a cohort study
title_full_unstemmed Marker events associated with adherence to HIV/AIDS treatment in a cohort study
title_short Marker events associated with adherence to HIV/AIDS treatment in a cohort study
title_sort marker events associated with adherence to hiv/aids treatment in a cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118423/
https://www.ncbi.nlm.nih.gov/pubmed/37075403
http://dx.doi.org/10.11606/s1518-8787.2023057004219
work_keys_str_mv AT martinsrafaelsteffens markereventsassociatedwithadherencetohivaidstreatmentinacohortstudy
AT knauthdanielariva markereventsassociatedwithadherencetohivaidstreatmentinacohortstudy
AT vigoalvaro markereventsassociatedwithadherencetohivaidstreatmentinacohortstudy
AT fischpatricia markereventsassociatedwithadherencetohivaidstreatmentinacohortstudy